500 USD
0.3
0.06%
Last update Dec 16, 3:59 PM EST
Post-market
Day range
491.76001
502.76999
Previous close
500.29999
Open
497.17001
Access this stock data via API
Subscribe
United Therapeutics Corporation
500.00
0.30
0.06%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 2.9B 2.3B 1.9B 1.7B
Cost of revenue 309.7M 257.5M 151.6M 122.5M
Gross profit 2.6B 2.1B 1.8B 1.6B
Operating expense
Research & development 481M 408M 322.9M 540.1M
Selling general and admin 638.6M 477.1M 482.1M 467M
Other operating expenses
Operating income 1.4B 1.2B 979.7M 555.9M
Non operating interest income
Income 199.1M 162.7M 45.2M 16.7M
Expense 42.9M 59.3M 32.4M 18.6M
Other income expense -65.3M -14M -41.9M 39.9M
Pretax income 1.5B 1.3B 950.6M 593.9M
Tax provision 343.9M 289.5M 223.3M 118.1M
Net income 1.2B 984.8M 727.3M 475.8M
Basic EPS 26.4 21.0 16.0 10.6
Diluted EPS 24.6 19.8 15 10.1
Basic average shares 45.2M 46.8M 45.5M 44.9M
Diluted average shares 45.2M 46.8M 45.5M 44.9M
EBITDA 1.7B 1.4B 1.0B 664.7M
Net income from continuing op. 1.2B 984.8M 727.3M 475.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 34 minutes

18:26
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).